Journal of APPLIED BIOMEDICINE
ISSN 1214-0287 (on-line)
ISSN 1214-021X (printed)

Volume 5 (2007), No 2, p 71-76




Down syndrome and coexistent autoimmune diseases

Dimitry Chistiakov

Address: Dimitry Chistiakov, Department of Pathology, University of Pittsburgh Medical Center, A719 Scaife Hall, 3550 Terrace st., Pittsburgh, PA15261, USA
dac58@pitt.edu

Received 30th November 2006.
Published online 22nd March 2007.

Full text article (pdf)
Full text article (html)

SUMMARY
Down syndrome (DS) is often accompanied by autoimmune diseases. Among those, autoimmune thyroid disease, type 1 diabetes and celiac disease are the most common. The major cause of enhanced vulnerability of DS patients to a variety of autoimmune diseases is impaired immune response, with multiple abnormalities in all components of the immune system, especially in cell-mediated immunity. This could explain a significantly higher frequency of autoimmune disorders in DS compared to the general population. The diagnosis of autoimmune diseases accompanying DS could be complicated by masking effects of the underlying features of the syndrome such as failure to thrive, short stature and delayed puberty. However, screening for immunological signs of coexistent autoimmunity such as tissue-specific antibodies and monitoring insulin secretion, glucose levels, thyroid function and other metabolic parameters should help in early diagnosis of coexistent autoimmunity in DS patiens.

KEY WORDS
autoimmune thyroid disease; celiac disease; coexistence; Down syndrome; type 1 diabetes


REFERENCES
Anwar AJ, Walker JD, Frier BM: Type 1 diabetes mellitus and Down's syndrome: prevalence, management and diabetic complications. Diabet Med 15:160-163, 1998.

Barankin B, Guenther L: Dermatological manifestations of Down's syndrome. J Cutan Med Surg 5:289-293, 2001.

Bertera S, Alexander A, Giannoukakis N, Robbins PD, Trucco M: Immunology of type 1 diabetes. Endocrinol Metab Clin North Am 28:841-846, 1999.

Book L, Hart A, Black J: Prevalence and clinical characteristics of celiac disease in Down's syndrome in a US study. Am J Med Genet 98:70-74, 2001.

Burch PRJ, Milunsky A: Early onset diabetes mellitus in the general and Down's syndrome populations. Lancet 1:554-558, 1969.

Carlstedt K, Krekmanova L, Dahllof, G, Ericsson, B, Braathen G, Modeer T: Oral carriage of Candida species in children and adolescents with Down's syndrome. Int J Paediatr Dent 6:95-100, 1996.

Carnicer J, Farre C, Varea V, Vilar P, Moreno J, Artigas J: Prevalence of coeliac disease in Down's syndrome. Eur J Gastroenterol Hepatol 13:263-267, 2001.

Chan KN, Phillips AD, Mirakian R, Walker-Smith JA: Endomysial antibody screening in children. J Pediatr Gastroenterol Nutr 18:316-320, 1994.

Corrao G, Corazzo GR, Andreani ML, Torchio P, Valentini RA, Galatola G, Quaglino D, Gasbarrini G, Diorio F: Serological screening of celiac disease: Choosing the optimal procedure according to various prevalence values. Gut 35:771-775, 1994.

Cuckle H: Biochemical screening for Down syndrome. Eur J Obstet Gynecol Reprod Biol 92:97-101, 2000.

DCCT Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993.

DCCT Research Group: Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial J Pediatr. 125:177-188, 1994.

Dietrich W, Ehnis, Bauer M, Donner P, Volta U, Riecken EO, Schuppan D: Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 3:797-801, 1997.

Feingold E, Lamb NE, Sherman SL: Methods for genetic linkage analysis using trisomies. Am J Hum Genet 56:475-483, 1990.

Fulcher T, Griffin M, Crowley S, Firth R, Acheson R, O'Meara N: Diabetic retinopathy in Down's syndrome. Br J Ophthalmol 82:407-409, 1998.

Goldacre MJ, Wotton CJ, Seagroatt V, Yeates D: Cancers and immune related diseases associated with Down's syndrome: a record linkage study. Arch Dis Child 89:1014-1017, 2004.

Griffin ME, Fulcher T, Nikookam K, Crowley J, Firth RG, OMeara NM. Down's syndrome, IDDM, and hypothyroidism. Diabetes Care 20:1202-1203, 1997.

Ivarsson SA, Ericsson VB, Gustafsson J, Forslund M, Forslund M, Vegfors P, Anneren G: The impact of thyroid autoimmunity in children and adolescents with Down syndrome. Acta Pediatr 86:1065-1067, 1997.

Jansson U, Johansson C: Down syndrome and celiac disease. J Pediatr Gastroenterol Nutrition 21:443-445, 1995.

Karlsson B, Gustafsson J, Hedov G, Ivarsson SA: Thyroid dysfunction in Down’s syndrome: relation to age and thyroid autoimmunity. Arch Dis Child 79:242-245, 1998.

Kennedy RL, Darne J: The role of hCG in regulation of the thyroid gland in normal and abnormal pregnancy. Obstet Gynecol 78:298-307, 1991.

Kinik ST, Ozcay F, Varan B: Type I diabetes mellitus, Hashimoto's thyroiditis and celiac disease in an adolescent with Down syndrome. Pediatr Int 48:433-435, 2006.

Knip M: Prediction and prevention of type 1 diabetes. Acta Paediatr Suppl 425:54-62, 1998.

Kraiem Z: The measurement of antithyroid autoantibodies in the diagnosis and management of thyroid autoimmune disease. Clin Rev Allergy Immunol 16:219-225, 1998.

Larocca LM, Lauriola L, Ranelleti FO, Piantelli M, Maggiano N, Ricci R, Capelli A: Morphological and immunohistochemical study of Down syndrome thymus. Am J Med Genet Suppl 7:225-230, 1990.

Lorini R, Gastaldi R, Traggiai C, Perucchin PP: Hashimoto's thyroiditis. Pediatr Endocrinol Rev. 2:205-211, 2003.

Lu CY, Changelian PS, Unanue ER: Alphafetoprotein inhibits macrophage expression of Ia antigens. J Immunol 132:1324-1327, 1984.

Maccario R, Ugazio AG, Nespoli L, Alberini C, Montagna D, Porta F, Bonetti F, Burgio GR: Lymphocyte subpopulations in Down's syndrome: high percentage of circulating HNK-1+, lue2a+ cells. Clin Exp Immunol 57:220-226, 1984.

Mahmoud SA, Lowery-Nordberg M, Chen H, Thurmon T, Ursin S, Bahna SL: Immune defects in subjects with dysmorphic disorders. Allergy Asthma Proc 26:373-381, 2005.

McCulloch AJ, Ince PG, Kendall-Taylor P: Autoimmune chronic active hepatitis in Down's syndrome. J Med Genet 19:232-234, 1982.

Mehta DI, Hill ID, Singer-Granick C et al.: Primary sclerosing cholangitis and multiple autoimmune disorders in a patient with Down syndrome. Clin Pediatr (Phila) 34:502-505, 1995.

Milunski A, Neurath PW: Diabetes mellitus in Down's syndrome. Arch Environ Health 17:372-376, 1968.

Murphy M, Hyun W, Hunte B, Levine A et al.: A role for tumor necrosis factor-alpha and interferon-gamma in the regulation of interleukin-4-induced human thymocyte proliferation in vitro. Heightened sensitivity in the Down syndrome (trisomy 21) thymus. Pediatr Res 32:269-276, 1992.

Murphy M, Insoft RM, Pike-Nobile L et al.: Overexpression of LFA-1 and ICAM-1 in Down syndrome thymus. Implications for abnormal thymocyte maturation. J Immunol 150:5696-5703, 1993.

Nespoli L, Burgio GR, Ugazio AG, Maccario R: Immunological features of Down syndrome: a review. J Intellect Disabil Res 37:543-551, 1993.

Philip R, Berger AC, McManus NH, Warner NH, Peacock MA, Epstein LB: Abnormalities in the in vitro cellular and humoral responses to tetanus and influenza antigens with concomitant numerical alterations in lymphocyte subsets in Down's syndrome (trisomy 21). J Immunol 136:1661-1667, 1986.

Pueschel SM, Pezzullo JC: Thyroid dysfunction in Down syndrome. Am J Dis Child 139:636-639, 1985.

Rubello D, Pozzan GB, Casara D, Girelli ME, Boccato S, Rigon F, Baccichetti C, Piccolo M, Betterle C, Busnardo B: Natural course of subclinical hypothyroidism in Downs syndrome - prospective study results and therapeutic considerations. J Endocrinol Invest 18:35-40, 1995.

Sare Z, Ruvalcaba RHA, Kelly VC: Prevalence of thyroid disorder in Down syndrome. Clin Genet 14:154-158, 1978.

Sharav T, Collins RM, Baab PJ: Growth studies in infants and children with Down’s syndrome and elevated levels of thyrotropin. Am J Dis Child 142:1302-1306, 1988.

Shield JPH, Wadsworth EJK, Hassold TJ, Judis LA, Jacobs PA: Is disomic homozygosity at the APECED locus the cause of increased autoimmunity in Down's syndrome? Arch Dis Child 81:147-150, 1999.

Tamiolakis D, Venizelos I, Kotini A, Nikolaidou S, Papadopoulos N: Prevalence of CD8/CD4 ratio in the fetal thymic parenchyme in Down's syndrome. Acta Medica (Hradec Kralove) 46:179-182, 2003.

VanGoor JC, Massa GG, Hirasing R: Increased incidence and prevalence of diabetes mellitus in Down's syndrome. Arch Dis Child 77:186, 1997.

Visakorpi J, Maki M: Changing clinical features of coeliac disease. Acta Paediatr Suppl 395:10-13, 1994.

Weetman AP: Chronic autoimmune thyroiditis. In Braverman LE, Utiger RD (eds.): The Thyroid, A Fundamental and Clinical Text, 8th ed., Lippincott Williams and Wilkins, Philadelphia 2000, pp. 721-732.

Zori RT, Schatz DA, Ostrer H, Williams CA, Spillar R, Riley WJ: Relationship of autoimmunity to thyroid dysfunction in children and adults with Down syndrome. Am J Med Genet Suppl 7:238-241, 1990.

Zubillaga P, Vitoria JC, Arrieta A, Echaniz P, Garciamasdevall MD: Down's syndrome and celiac disease. J Pediatr Gastroenterol Nutr 16:168-171, 1993.
CITED

Nabavi SM, Hamzehloo A, Sabet Z. Down syndrome presenting with multiple sclerosis, thyroid dysfunction, and diabetes mellitus Multiple autoimmune disorders in a genetic disorder. Neurosci. 16: 375-377, 2011.

BACK